home / stock / iccc / iccc news

ICCC News and Press, ImmuCell Corporation

Stock Information
Company Name: ImmuCell Corporation
Stock Symbol: ICCC
Market: NASDAQ
Website: immucell.com
Menu
Get ICCC Alerts

News, Short Squeeze, Breakout and More Instantly...
ICCC - ImmuCell outlines plan to boost First Defense capacity to 5-6M units while strengthening U.S. market share

2026-03-05 15:06:43 ET More on ImmuCell ImmuCell Corporation (ICCC) Q4 2025 Earnings Call Transcript ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript ImmuCell reports preliminary Q4 results Seeking Alpha’s Quant Rating on ImmuCell ...
ICCC - ImmuCell Corporation (ICCC) Q4 2025 Earnings Call Transcript

2026-03-05 15:05:58 ET ImmuCell Corporation (ICCC) Q4 2025 Earnings Call March 5, 2026 9:00 AM EST Company Participants P. F. Te Boekhorst - President, CEO & Director Timothy Fiori - CFO, Secretary, Treasurer & Director ... Read the full article on Seek...

ICCC - ImmuCell GAAP EPS of -$0.31, revenue of $7.62M

2026-03-04 16:16:08 ET More on ImmuCell ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript ImmuCell reports preliminary Q4 results Seeking Alpha’s Quant Rating on ImmuCell Financial information for ImmuCell Read the full articl...

ICCC - ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025

PORTLAND, Maine, March 04, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, today announced its...
ICCC - ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025

PORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, expects to report unaudited fi...

ICCC - ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript

2026-01-09 12:24:49 ET ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call January 9, 2026 9:00 AM EST... Read the full article on Seeking Alpha For further details see: ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript

ICCC - ImmuCell reports preliminary Q4 results

2026-01-08 16:28:29 ET More on ImmuCell ImmuCell Corporation (ICCC) Q3 2025 Earnings Call Transcript ImmuCell Corporation: At A Major Inflection Point ImmuCell signals operational excellence and targets $30M annual production capacity amid management transition ...
ICCC - ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025

PORTLAND, Maine, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, today announced prelimina...

ICCC - ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus

PORTLAND, Maine, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, plans to conduct a conference ...

ICCC - ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®

PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity today announced that it received an Incomplete Letter fro...
Next 10